Malaria Clinical Trial 2007-100

[LCID Study Number: 2007-100]

IND Protocol: Intravenous Artesunate For Treatment Of Severe Malaria In The United States

The purpose of this study is to make available intravenous artesunate for treatment of severe malaria in US hospitals when parenteral quinidine cannot be used due to unavailability, intolerance, contraindications, or parasite non-response.

Disease/Condition: Malaria

Department: Infectious Disease

Location(s): Lahey Hospital & Medical Center (Burlington)

Primary Contact Email: [email protected]

Primary Contact Phone: 781-744-2734

Protocol #: 2007-100
Principal Investigator(s): Winnie W Ooi
Study Coordinator(s): Deborah Gannon
Trial Phase: Sponsor Initiated Study Expanded Access